Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid

Stroke

Volumn 38, Issue 12, 2007, Pages 3245-3250

  Whitehead, Shawn N ^a   Cheng, Guanliang ^a   Hachinski, Vladimir C ^a   Cechetto, David F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

A peptide; Alzheimer's disease; Memory; Neuroinflammation; Rat; Stroke

Indexed keywords

AMYLOID BETA PROTEIN; ENDOTHELIN 1;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; INFLAMMATION; LEARNING DISORDER; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MEMORY; NERVOUS SYSTEM DISEASES; RATS; RATS, WISTAR; STROKE; TIME FACTORS;

EID: 36448932405     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.492660     Document Type: Article

References (32)

1. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van HF, van Duijn CN, Van BC, Grobbee DE. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349:151-154.
2. Aharon-Peretz J, Harel T, Revach M, Ben-Haim SA. Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer's disease. Arch Neurol. 1992;49:919-922.
3. Ott A, Breteler MM, de Bruyne MC, van HF, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke. 1997;28:316-321.
4. Kalaria R. Similarities between Alzheimer's disease and vascular dementia. J Neurol Sci. 2002;203-204:29-34.
5. Small G. Meeting the challenges of vascular dementia. Introduction. Int J Clin Pract Suppl. 2001;120:1-4.
6. Jendroska K, Poewe W, Daniel SE, Pluess J, Iwerssen-Schmidt H, Paulsen J, Barthel S, Schelosky L, Cervos-Navarro J, DeArmond SJ. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol (Berl). 1995;90:461-466.
7. Jendroska K, Hoffmann OM, Patt S. Amyloid beta peptide and precursor protein (APP) in mild and severe brain ischemia. Ann N Y Acad Sci. 1997;826:401-405.
8. Nakamura Y, Takeda M, Niigawa H, Hariguchi S, Nishimura T. Amyloid beta-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection. Neurosci Lett. 1992;136:95-98.
9. Kalaria RN, Bhatti SU, Palatinsky EA, Pennington DH, Shelton ER, Chan HW, Perry G, Lust WD. Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. Neuroreport. 1993;4:211-214.
10. Bhatia R, Lin H, Lal R. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J. 2000;14:1233-1243.
11. Preston JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN. Toxic effects of beta-amyloid (25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett. 1998;242:105-108.
12. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813-817.
13. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology. 1998;51:159-162.
14. Arvin B, Neville LF, Barone FC, Feuerstein GZ. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev. 1996;20:445-452.
15. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci. 1997;17:2746-2755.
16. Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol. 1998;56:149-171.
17. Bales KR, Du Y, Holtzman D, Cordell B, Paul SM. Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E. Neurobiol Aging. 2000;21:427-432.
18. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995;21:195-218.
19. McGeer PL, McGeer EG, Yasojima K. Alzheimer disease and neuroinflammation. J Neural Transm Suppl. 2000;59:53-57.
20. Cheng G, Whitehead SN, Hachinski V, Cechetto DF. Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat. Neurobiol Dis. 2006;23:140-151.
21. Whitehead S, Cheng G, Hachinski V, Cechetto DF. Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: II. Effects of Triflusal. Stroke. 2005;36:1782-1789.
22. Whitehead SN, Hachinski VC, Cechetto DF. Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: inflammatory responses. Stroke. 2005;36:107-112.
23. Bayona NA, Gelb AW, Jiang Z, Wilson JX, Urquhart BL, Cechetto DF. Propofol neuroprotection in cerebral ischemia and its effects on low-molecular-weight antioxidants and skilled motor tasks. Anesthesiology. 2004;100:1151-1159.
24. Sigurdsson EM, Lee JM, Dong XW, Hejna MJ, Lorens SA. Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects. Neurobiol Aging. 1997;18:591-608.
25. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd ed. London: Academic Press Inc; 1986.
26. Kiernan JA. Histological and Histochemical Methods. Theory and Practice, 3rd ed. Oxford: Butterworth Heinemann; 1999.
27. Barnes CA. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol. 1979; 93:74-104.
28. Abe K, Tanzi RE, Kogure K. Induction of HSP70 mRNA after transient ischemia in gerbil brain. Neurosci Lett. 1991;125:166-168.
29. Abe K, Tanzi RE, Kogure K. Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett. 1991;125:172-174.
30. Banati RB, Gehrmann J, Wiessner C, Hossmann KA, Kreutzberg GW. Glial expression of the beta-amyloid precursor protein (APP) in global ischemia. J Cereb Blood Flow Metab. 1995;15:647-654.
31. Stephenson DT, Rash K, Clemens JA. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 1992;593:128-135.
32. Zhang F, Eckman C, Younkin S, Hsiao KK, Iadecola C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J Neurosci. 1997;17:7655-7661.